Rayomand J. Unwalla
Pfizer (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Estrogen and related hormone effects, Cholesterol and Lipid Metabolism, Peroxisome Proliferator-Activated Receptors, Computational Drug Discovery Methods
Most-Cited Works
- → Understanding the Selectivity of Genistein for Human Estrogen Receptor-β Using X-Ray Crystallography and Computational Methods(2004)187 cited
- → Structure-Based Design of Estrogen Receptor-β Selective Ligands(2004)175 cited
- → Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists(1997)86 cited
- → ERβ ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor β-selective ligands(2007)78 cited
- → Molecular and Pharmacological Properties of a Potent and Selective Novel Nonsteroidal Progesterone Receptor Agonist Tanaproget(2005)76 cited
- → Indazole-Based Liver X Receptor (LXR) Modulators with Maintained Atherosclerotic Lesion Reduction Activity but Diminished Stimulation of Hepatic Triglyceride Synthesis(2008)75 cited
- → Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones(2005)72 cited
- → Insights for Predicting Blood-Brain Barrier Penetration of CNS Targeted Molecules Using QSPR Approaches(2010)65 cited
- → Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates(2010)53 cited
- → Discovery of Phenyl Acetic Acid Substituted Quinolines as Novel Liver X Receptor Agonists for the Treatment of Atherosclerosis(2006)50 cited